Literature DB >> 7340881

The effect of frusemide and piretanide on the renal clearance of gentamicin in man.

P H Whiting, H E Barber, J Petersen.   

Abstract

1 Gentamicin alone (dose 1 mg/kg) or in combination with frusemide (dose 0.25 mg/kg) or piretanide (dose 0.1 mg/kg) was administered intravenously to six healthy male volunteers. 2 Blood samples were collected at various times for 24 h and urine for up to 48 h. 3 Both diuretics increased the renal clearance of gentamicin during the period of the diuresis, without influencing either the glomerular filtration rate or the distribution of the antibiotic. 4 The results are discussed in relation to gentamicin-induced nephrotoxicity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7340881      PMCID: PMC1401925          DOI: 10.1111/j.1365-2125.1981.tb01309.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  18 in total

1.  Renal extraction of gentamicin in anesthetized dogs.

Authors:  P J Chiu; A Brown; G Miller; J F Long
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

2.  Renal clearance and tissue accumulation of gentamicin.

Authors:  J J Schentag; W J Jusko
Journal:  Clin Pharmacol Ther       Date:  1977-09       Impact factor: 6.875

3.  Nephrotoxicity of gentamicin.

Authors:  J C Kosek; R I Mazze; M J Cousins
Journal:  Lab Invest       Date:  1974-01       Impact factor: 5.662

4.  Glomerular filtration rate measurement in man by the single injection methods using 51Cr-EDTA.

Authors:  C Chantler; E S Garnett; V Parsons; N Veall
Journal:  Clin Sci       Date:  1969-08       Impact factor: 6.124

5.  Furosemide binding to human albumin and plasma of nephrotic children.

Authors:  J Prandota; A W Pruitt
Journal:  Clin Pharmacol Ther       Date:  1975-02       Impact factor: 6.875

6.  Renal damage caused by gentamicin: a study of the effects on renal morphology and urinary enzyme excretion.

Authors:  J M Wellwood; D Lovell; A E Thompson; J R Tighe
Journal:  J Pathol       Date:  1976-03       Impact factor: 7.996

7.  Renal tubular secretion and effects of furosemide.

Authors:  B Odlind; B Beermann
Journal:  Clin Pharmacol Ther       Date:  1980-06       Impact factor: 6.875

8.  Gentamicin nephrotoxicity in rats. I. Acute biochemical and ultrastructural effects.

Authors:  J Vera-Roman; T P Krishnakantha; F E Cuppage
Journal:  Lab Invest       Date:  1975-10       Impact factor: 5.662

9.  Gentamicin pharmacokinetics during hemodialysis in patients suffering from chronic renal failure.

Authors:  L Létourneau-Saheb; L Lapierre; R Daigneault; M Prud'Homme; G St-Louis; G Serois
Journal:  Int J Clin Pharmacol Biopharm       Date:  1977-03

10.  Gentamicin-induced nephrotoxicity in mice: protection by loop diuretics.

Authors:  P H Whiting; J Petersen; J G Simpson
Journal:  Br J Exp Pathol       Date:  1981-04
View more
  6 in total

Review 1.  Clinical pharmacology of antibiotics and other drugs in cystic fibrosis.

Authors:  J Prandota
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

Review 2.  The management of hypertension.

Authors:  B N Prichard; C W Owens
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

3.  The toxic effects of combined administration of cyclosporin A and gentamicin.

Authors:  P H Whiting; J G Simpson; R J Davidson; A W Thomson
Journal:  Br J Exp Pathol       Date:  1982-10

Review 4.  Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

5.  Improvement in angina pectoris with alpha adrenoceptor blockade.

Authors:  P Collins; D Sheridan
Journal:  Br Heart J       Date:  1985-05

Review 6.  Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions.

Authors:  F Pea; M Furlanut
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 5.577

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.